NanoGhost
Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.
About
Technology stack
detected 2026-06-15No comments yet. Be the first to share your take.
What does NanoGhost do?
NanoGhost is a biotechnology company focused on developing a highly selective, first-in-class drug delivery platform. Their platform, 'Nano-Ghosts' (NGs), is derived from the cell membrane of mesenchymal stem cells (MSCs), which naturally target cancer and sites of inflammation. This versatile technology aims to provide highly selective drug targeting for various therapeutic applications.
Where is NanoGhost headquartered?
NanoGhost is headquartered in Tel Aviv, Israel.
When was NanoGhost founded?
NanoGhost was founded in 2019.
What industry does NanoGhost operate in?
NanoGhost operates in Life Sciences, Drug Delivery, Biotech, Oncology, Immunology, Drug Discovery.
How many employees does NanoGhost have?
NanoGhost has approximately 11 people on record.